Crossmark

Adherence to subcutaneous biologic treatment for inflammatory bowel disease

Crossref DOI link: https://doi.org/10.1016/j.gastre.2021.04.010

Published Print: 2022-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ramos, Laura

Ramos-Rodríguez, Javier

Barreda, Raquel De La

Gutiérrez-Nicolás, Fernando

Carrillo-Palau, Marta

Alonso-Abreu, Inmaculada

Nazco-Casariego, Julia

Quintero, Enrique
License Information

Text and Data Mining valid from 2022-05-01

stm-asf valid from 2022-05-01

stm-asf valid from 2022-05-01

stm-asf valid from 2022-05-01

stm-asf valid from 2022-05-01

stm-asf valid from 2022-05-01
More Information

This article is maintained by: Elsevier

Article Title: Adherence to subcutaneous biologic treatment for inflammatory bowel disease

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2021.04.010

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.gastrohep.2021.04.011

Content Type: article

Copyright: © 2021 Elsevier España, S.L.U. All rights reserved.